| Literature DB >> 32628051 |
Abstract
New COVID-19 skin manifestations continue to be described. We present a patient with COVID-19 related anagen effluvium. The patient was treated with and responded to low dose systemic steroids to treat an accompanying extensive COVID-19-related urticaria and maculopapular rash.Entities:
Keywords: Anagen effluvium; COVID-19 cutaneous manifestations; COVID-19 hair manifestations
Mesh:
Year: 2020 PMID: 32628051 DOI: 10.1080/09546634.2020.1792400
Source DB: PubMed Journal: J Dermatolog Treat ISSN: 0954-6634 Impact factor: 3.359